Agronomics Limited Announces Onego Bio Update

Core Insights - Onego Bio Limited has received a "no questions" letter from the FDA regarding the GRAS status of its product Bioalbumen®, confirming its safety for use in various food and beverage applications [1] Company Summary - Onego Bio is a food ingredient company that specializes in producing egg protein through precision fermentation [1] - The FDA's decision supports Onego Bio's conclusion that Bioalbumen® is Generally Recognized As Safe (GRAS) under specified conditions of use [1] Industry Context - The issuance of a "no questions" letter from the FDA is a significant milestone for companies in the food ingredient sector, as it validates the safety of their products for consumer use [1]